|
Delayed
OTC Markets
15:41:07 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 3.91M 2.77M 2.46M 2.28M 2.07M 262M 3.97M 27.38M 10.74M 137M 10.38M 10.16M 437M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.46M 5.74M 5.32M 4.84M 613M 9.28M 63.95M 25.07M 320M 24.23M 23.72M 1.02B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.02 | |
| 10 years | 0 | 16.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/2017 |
| Corporate Officer/Principal | - | 29/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 23/05/2017 |
| Director/Board Member | - | 29/08/2018 | |
| Director/Board Member | - | 20/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 128 | ||
| -0.10% | +6.59% | +56.57% | +107.01% | 1,120B | ||
| -0.21% | -2.25% | +32.26% | +67.33% | 616B | ||
| +0.06% | +3.24% | +24.33% | +91.20% | 504B | ||
| +0.13% | +5.11% | +34.61% | +58.69% | 367B | ||
| +0.68% | +0.24% | +72.13% | +43.10% | 360B | ||
| -0.34% | +3.32% | +19.01% | +46.24% | 288B | ||
| -0.06% | +2.58% | -1.81% | +17.62% | 258B | ||
| -0.21% | +4.25% | +44.74% | +52.51% | 234B | ||
| +0.21% | +3.32% | +27.18% | +96.05% | 194B | ||
| Average | +0.06% | +2.98% | +34.34% | +64.42% | 394.09B | |
| Weighted average by Cap. | -0.00% | +3.52% | +39.32% | +74.39% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.53M 12.03M 11.15M 10.14M 1.28B 19.44M 134M 52.53M 670M 50.77M 49.69M 2.14B | 22.25M 15.73M 13.98M 12.96M 11.79M 1.49B 22.6M 156M 61.07M 779M 59.03M 57.77M 2.48B |
| Net income | -36.02M -25.47M -22.64M -20.98M -19.09M -2.42B -36.6M -252M -98.88M -1.26B -95.57M -93.54M -4.02B | -126M -89.01M -79.13M -73.34M -66.73M -8.45B -128M -882M -346M -4.41B -334M -327M -14.05B |
| Net Debt | -15.55M -10.99M -9.77M -9.06M -8.24M -1.04B -15.8M -109M -42.68M -544M -41.26M -40.38M -1.74B | 5.22M 3.69M 3.28M 3.04M 2.77M 350M 5.31M 36.56M 14.33M 183M 13.86M 13.56M 583M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ISOLF Stock
Select your edition
All financial news and data tailored to specific country editions
















